0001127602-18-017761.txt : 20180516
0001127602-18-017761.hdr.sgml : 20180516
20180516183125
ACCESSION NUMBER: 0001127602-18-017761
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180509
FILED AS OF DATE: 20180516
DATE AS OF CHANGE: 20180516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pletcher Brett A
CENTRAL INDEX KEY: 0001739307
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 18841314
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: X1
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
3
1
form3.xml
PRIMARY DOCUMENT
X0206
3
2018-05-09
0
0000882095
GILEAD SCIENCES INC
GILD
0001739307
Pletcher Brett A
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
EVP, Gen Counsel & Corp Sec
Common Stock
18941
D
Non-qualified Stock Option (Right to Buy)
24.905
2019-07-29
Common Stock
7200
D
Non-qualified Stock Option (Right to Buy)
16.89
2020-07-22
Common Stock
2400
D
Non-qualified Stock Option (Right to Buy)
24.295
2022-01-26
Common Stock
35400
D
Non-qualified Stock Option (Right to Buy)
40.56
2023-02-01
Common Stock
32560
D
Non-qualified Stock Option (Right to Buy)
80.65
2024-02-01
Common Stock
25780
D
Non-qualified Stock Option (Right to Buy)
104.83
2025-02-01
Common Stock
23460
D
Non-qualified Stock Option (Right to Buy)
116.58
2025-08-10
Common Stock
14830
D
Non-qualified Stock Option (Right to Buy)
84.05
2026-02-01
Common Stock
53590
D
Non-qualified Stock Option (Right to Buy)
72.25
2027-02-02
Common Stock
73480
D
Non-qualified Stock Option (Right to Buy)
83.49
2028-02-01
Common Stock
69200
D
Restricted Stock Unit
Common Stock
4140
D
The shares subject to the option have a five-year vesting schedule. 20% vest on the first anniversary of the date of the grant. The balance will vest 5% quarterly thereafter until fully vested.
The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
/s/ Brett A. Pletcher
2018-05-16
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): POAPLETCHER050818
Power of Attorney
Know all by these presents, that the undersigned hereby
constitutes and appoints each of Robin L. Washington, Gregg H. Alton,
Katie Watson, Jason Okazaki, Diane Wilfong and
Marissa Song, signing individually, the undersigned?s true and lawful
attorneys-in-fact and agents to:
(1) execute for and on behalf of the undersigned, an officer or
director of Gilead Sciences, Inc. (the ?Company?), Forms 3, 4 and
5 in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended (the ?Exchange Act?) and the rules there under;
(2) do and perform any and all acts for and on behalf of the undersigned
that may be necessary or desirable to complete and execute such Form 3, 4
or 5, complete and execute and amendment or amendments thereto, and timely
file such forms or amendments with United States Securities and Exchange
Commission and any stock exchange or similar authority; and
(3)take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this
Power of Attorney shall be in such form and shall contain such terms
and conditions as such attorney-in-fact may approve in such
attorney-in-fact?s discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing
whatsoever requisite, necessary, or proper to be done in the exercise of
any of the rights and powers herein granted, fully to all intents and
purpose as the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact?s substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power
of attorney and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such
capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned?s responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect
until the earliest to occur of (a) the undersigned is no longer required
to file Forms 3, 4 and 5 with respect to the undersigned?s holdings of
and transactions in securities issued by the Company, (b) revocation by
the undersigned in a signed writing delivered to the foregoing
attorney?s-in-fact or (c) as to any attorney-in-fact individually, until
such attorney-in-fact shall no longer be employed by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 8th day of May 2018.
/s/Brett A. Pletcher